←
Mike Gallagher4,440 posts
Mike Gallagher avatar

Mike Gallagher

@GeneticsMike7

Incoming Assistant Professor @ ASU-Banner Neurodegenerative Disease Research Center/SOLS. #neurodegeneration #neuroimmunology #iPSC #functionalgenomics

◷ Joined May 2021▧ 43 Photos and videos
Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·Oct 25

1/ I'm very happy to announce that the Gallagher lab will be opening at the new ASU-Banner Neurodegenerative Research Center in January 2027! We will be using iPSC-based systems to study the role of microglia (and other cells) in brain health and disease,

Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·Oct 25

3/ Please see below for the website (still a work in progress), contact me if interested, and spread the word if you know anyone who might be! The center is in the beautiful new Biodesign C building with a close-knit group of (mostly young) faculty who are highly collaborative

Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·Oct 25

2/ focusing on neurodegeneration. We will be employing new CRISPR-based and transgenic approaches developed in my postdoc, and are looking for interested lab techs, undergrads, MS or PhD students, postdocs, bioinformaticians, and a lab manager.

Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

21/ in summary, this "iPSC-Xon" system overcomes critical limitations in current transgene systems in hPSC-based work, and will benefit from additional improvements. I'm on the job market and would love to bring and improve this technology to other researchers!

Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

20/ strangely, leaky SALL1 is not due to unwanted splicing in the absence of drug, but rather the unspliced pre-mRNA somehow escapes the nucleus and is translated in-frame to make the full-length protein. We still don't know how this works.

Post attachment
Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

19/ we thought larger transgenes (Cas9 is ~4kb) might be more prone to disrupting the Xon splicing switch, so we tried the ~4kb SALL1 TF, a critical driver of microglia homeostatic function. In contrast with EGFP, Xon-SALL1 is fully leaky and shows aberrant splicing patterns.

Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

18/ we also show that we can get inducible gene editing with Xon hPSCs, but only if sgRNAs are introduced transiently. Cas9 has enough leakiness for maximal editing with constitutive lentiviral sgRNA introduced into hPSCs

Post attachment
Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

17/ what about other genes? Here we show Xon works for inducible control of GRN expression, and we can overexpress GRN in iPSC-derived microglia, which already express boatloads of it. P2A peptides improve both GRN and SMAD, and importantly reduce N-terminal tag to a single aa.

Post attachment
Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

16/ a couple important points here: in addition to resisting silencing and being highly tunable, Xon adds only 24aa N-terminal tag and needs only low nM drug doses, whereas degrons add ~500bp tags to BOTH termini to be effective, and need low uM drug doses.

Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

15/ a note of caution is that while background EGFP is minor compared to even the lowest drug induced expression levels, this may need mitigation when using TFs or other strong cell state regulators

Post attachment
Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

14/ Here's the commonly used H1 ESC background, differentiated into microglia with an embryoid body protocol (we used EB and monolayer)

Post attachment
Mike Gallagher avatar
Mike Gallagher@GeneticsMike7·2 Nov 2025

13/ quantification shows how tunable this system really is! Below the 100nM dose, linear correlations between drug dose and EGFP is basically perfect both before and after differentiation

Post attachment